Andrew Roddam

Our Future Health UK is a collaboration between the public, private, and charity sectors. Our Future Health UK is a member of the UK Health Data Research Alliance, which establishes best practices for the ethical use of UK health data for research at scale. The private company is based in Manchester, UK. The British company aims to be the largest health research program in the UK, bringing people together to develop new ways to prevent, detect, and treat diseases. The company is committed to protecting participants' confidentiality while maximizing the opportunity to help researchers tackle serious diseases. The CEO of the company is Andrew Roddam.

Our Future Health UK is a collaboration between the public, private, and charity sectors. Our Future Health UK is a member of the UK Health Data Research Alliance, which establishes best practices for the ethical use of UK health data for research at scale. The private company is based in Manchester, UK. The British company aims to be the largest health research program in the UK, bringing people together to develop new ways to prevent, detect, and treat diseases. The company is committed to protecting participants' confidentiality while maximizing the opportunity to help researchers tackle serious diseases. The CEO of the company is Andrew Roddam.

International Health Terminology Standards Development improves healthcare by setting standards for a codified language that represents clinical terms. The non-profit company is based in London, UK. This enables healthcare information to be exchanged efficiently for the benefit of patients and other stakeholders. Snomed International, a not-for-profit organization, owns and develops Snomed CT, the world's most comprehensive healthcare terminology product. The CEO of the British company is Don Sweete.

International Health Terminology Standards Development improves healthcare by setting standards for a codified language that represents clinical terms. The non-profit company is based in London, UK. This enables healthcare information to be exchanged efficiently for the benefit of patients and other stakeholders. Snomed International, a not-for-profit organization, owns and develops Snomed CT, the world's most comprehensive healthcare terminology product. The CEO of the British company is Don Sweete.

International Health Terminology Standards Development improves healthcare by setting standards for a codified language that represents clinical terms. The non-profit company is based in London, UK. This enables healthcare information to be exchanged efficiently for the benefit of patients and other stakeholders. Snomed International, a not-for-profit organization, owns and develops Snomed CT, the world's most comprehensive healthcare terminology product. The CEO of the British company is Don Sweete.

International Health Terminology Standards Development improves healthcare by setting standards for a codified language that represents clinical terms. The non-profit company is based in London, UK. This enables healthcare information to be exchanged efficiently for the benefit of patients and other stakeholders. Snomed International, a not-for-profit organization, owns and develops Snomed CT, the world's most comprehensive healthcare terminology product. The CEO of the British company is Don Sweete.

Our Future Health UK is a collaboration between the public, private, and charity sectors. Our Future Health UK is a member of the UK Health Data Research Alliance, which establishes best practices for the ethical use of UK health data for research at scale. The private company is based in Manchester, UK. The British company aims to be the largest health research program in the UK, bringing people together to develop new ways to prevent, detect, and treat diseases. The company is committed to protecting participants' confidentiality while maximizing the opportunity to help researchers tackle serious diseases. The CEO of the company is Andrew Roddam.

International Health Terminology Standards Development improves healthcare by setting standards for a codified language that represents clinical terms. The non-profit company is based in London, UK. This enables healthcare information to be exchanged efficiently for the benefit of patients and other stakeholders. Snomed International, a not-for-profit organization, owns and develops Snomed CT, the world's most comprehensive healthcare terminology product. The CEO of the British company is Don Sweete.

Our Future Health UK is a collaboration between the public, private, and charity sectors. Our Future Health UK is a member of the UK Health Data Research Alliance, which establishes best practices for the ethical use of UK health data for research at scale. The private company is based in Manchester, UK. The British company aims to be the largest health research program in the UK, bringing people together to develop new ways to prevent, detect, and treat diseases. The company is committed to protecting participants' confidentiality while maximizing the opportunity to help researchers tackle serious diseases. The CEO of the company is Andrew Roddam.

Our Future Health UK is a collaboration between the public, private, and charity sectors. Our Future Health UK is a member of the UK Health Data Research Alliance, which establishes best practices for the ethical use of UK health data for research at scale. The private company is based in Manchester, UK. The British company aims to be the largest health research program in the UK, bringing people together to develop new ways to prevent, detect, and treat diseases. The company is committed to protecting participants' confidentiality while maximizing the opportunity to help researchers tackle serious diseases. The CEO of the company is Andrew Roddam.

Our Future Health UK is a collaboration between the public, private, and charity sectors. Our Future Health UK is a member of the UK Health Data Research Alliance, which establishes best practices for the ethical use of UK health data for research at scale. The private company is based in Manchester, UK. The British company aims to be the largest health research program in the UK, bringing people together to develop new ways to prevent, detect, and treat diseases. The company is committed to protecting participants' confidentiality while maximizing the opportunity to help researchers tackle serious diseases. The CEO of the company is Andrew Roddam.

Our Future Health UK is a collaboration between the public, private, and charity sectors. Our Future Health UK is a member of the UK Health Data Research Alliance, which establishes best practices for the ethical use of UK health data for research at scale. The private company is based in Manchester, UK. The British company aims to be the largest health research program in the UK, bringing people together to develop new ways to prevent, detect, and treat diseases. The company is committed to protecting participants' confidentiality while maximizing the opportunity to help researchers tackle serious diseases. The CEO of the company is Andrew Roddam.

Our Future Health UK is a collaboration between the public, private, and charity sectors. Our Future Health UK is a member of the UK Health Data Research Alliance, which establishes best practices for the ethical use of UK health data for research at scale. The private company is based in Manchester, UK. The British company aims to be the largest health research program in the UK, bringing people together to develop new ways to prevent, detect, and treat diseases. The company is committed to protecting participants' confidentiality while maximizing the opportunity to help researchers tackle serious diseases. The CEO of the company is Andrew Roddam.

Our Future Health UK is a collaboration between the public, private, and charity sectors. Our Future Health UK is a member of the UK Health Data Research Alliance, which establishes best practices for the ethical use of UK health data for research at scale. The private company is based in Manchester, UK. The British company aims to be the largest health research program in the UK, bringing people together to develop new ways to prevent, detect, and treat diseases. The company is committed to protecting participants' confidentiality while maximizing the opportunity to help researchers tackle serious diseases. The CEO of the company is Andrew Roddam.